Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R. Idle
Metabolites (2020) Vol. 10, Iss. 2, pp. 50-50
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress
Alimire Abulikemu, Xinying Zhao, Hailin Xu, et al.
Redox Biology (2022) Vol. 59, pp. 102569-102569
Open Access | Times Cited: 71
Recurrent Topics in Mass Spectrometry-Based Metabolomics and Lipidomics—Standardization, Coverage, and Throughput
Evelyn Rampler, Yasin El Abiead, Harald Schoeny, et al.
Analytical Chemistry (2020) Vol. 93, Iss. 1, pp. 519-545
Open Access | Times Cited: 127
Multiplatform Untargeted Metabolomics
Micah J. Jeppesen, Robert Powers
Magnetic Resonance in Chemistry (2023) Vol. 61, Iss. 12, pp. 628-653
Open Access | Times Cited: 27
Lycopene: A Potent Antioxidant with Multiple Health Benefits
Mercy Omoye Shafe, Nontobeko Myllet Gumede, Trevor Tapiwa Nyakudya, et al.
Journal of Nutrition and Metabolism (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 13
Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study
Yang Du, Lei Chen, Xuesong Li, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 3, pp. 615-623
Open Access | Times Cited: 60
Metabolic Rewiring and the Characterization of Oncometabolites
Diren Beyoğlu, Jeffrey R. Idle
Cancers (2021) Vol. 13, Iss. 12, pp. 2900-2900
Open Access | Times Cited: 43
Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes
Yan Zhang, Feng Liang, DuoDuo Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114046-114046
Open Access | Times Cited: 35
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma
Jiaqi Sun, Jun Ding, Qingsong Shen, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 627-642
Closed Access | Times Cited: 28
Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis
Dongmei Qin, P Pan, Bo Lyu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116942-116942
Open Access | Times Cited: 5
Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome
Clara Depommier, Amandine Everard, Céline Druart, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Urine surface-enhanced Raman spectroscopy combined with SVM algorithm for rapid diagnosis of liver cirrhosis and hepatocellular carcinoma
Wubulitalifu Dawuti, Xiangxiang Zheng, Hui Liu, et al.
Photodiagnosis and Photodynamic Therapy (2022) Vol. 38, pp. 102811-102811
Closed Access | Times Cited: 24
LC-MS/MS-based targeted amino acid metabolic profile of Auricularia cornea grown on pinecone substrate
Lei Ye, Bo Zhang, Jie Zhou, et al.
Food Chemistry (2023) Vol. 432, pp. 137247-137247
Closed Access | Times Cited: 14
Effects of Cadmium on Liver Function and its Metabolomics Profile in the Guizhou Black Goat
Yuanfeng Li, Xiaoyun Shen
Metabolites (2023) Vol. 13, Iss. 2, pp. 268-268
Open Access | Times Cited: 13
Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease
Bei Gao, Sonja Lang, Yi Duan, et al.
Digestive Diseases and Sciences (2019) Vol. 64, Iss. 7, pp. 1878-1892
Open Access | Times Cited: 39
Microbiome and Metabolomics in Liver Cancer: Scientific Technology
Raja Ganesan, Sang Jun Yoon, Ki Tae Suk
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 537-537
Open Access | Times Cited: 20
The Uses of Anabolic Androgenic Steroids Among Athletes; Its Positive and Negative Aspects- A Literature Review
Zhang Wen-bo, Yan Zhang
Journal of Multidisciplinary Healthcare (2023) Vol. Volume 16, pp. 4293-4305
Open Access | Times Cited: 11
Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β‐catenin signaling and tumor growth
Yagmur Azbazdar, Yeliz Demirci, Guillaume Heger, et al.
Molecular Oncology (2023) Vol. 17, Iss. 11, pp. 2314-2336
Open Access | Times Cited: 10
A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients
Meera Shanmuganathan, M. Omair Sarfaraz, Zachary Kroezen, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 24
Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease
Yuping Zeng, He He, Zhenmei An
Disease Markers (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 17
Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis
Diren Beyoğlu, Pinzhu Huang, Disha Skelton-Badlani, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 485-485
Open Access | Times Cited: 9
Automated identification and quantification of metabolites in human fecal extracts by nuclear magnetic resonance spectroscopy
Brian L. Lee, Manoj Kumar Rout, Rupasri Mandal, et al.
Magnetic Resonance in Chemistry (2023) Vol. 61, Iss. 12, pp. 705-717
Open Access | Times Cited: 8
The Metabolomic Footprint of Liver Fibrosis
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
Cells (2024) Vol. 13, Iss. 16, pp. 1333-1333
Open Access | Times Cited: 2
Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12809-12809
Open Access | Times Cited: 2
Metabolomic insights into the mode of action of natural products in the treatment of liver disease
Diren Beyoğlu, Jeffrey R. Idle
Biochemical Pharmacology (2020) Vol. 180, pp. 114171-114171
Closed Access | Times Cited: 21
Biomarkers of Cholestasis
Alanah Pieters, Eva Gijbels, Bruno Cogliati, et al.
Biomarkers in Medicine (2021) Vol. 15, Iss. 6, pp. 437-454
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top